Acadia Pharmaceuticals

(NASDAQ) ACAD

Current Price$21.96

Market Cap$3.76B

Since IPO (2004)+228%

5 Year+7%

1 Year+51%

1 Month-2%

Acadia Pharmaceuticals Financials at a Glance

Market Cap

$3.76B

Revenue (TTM)

$1.07B

Net Income (TTM)

$391.00M

EPS (TTM)

$2.29

P/E Ratio

9.59

Dividend

$0.00

Beta (Volatility)

0.96 (Low)

Dividend

$0.00

Beta (Volatility)

0.96 (Low)

Price

$21.96

Volume

1,449,400.349

Open

$22.31

Price

$21.96

Volume

1,449,400.349

Open

$22.31

Previous Close

$21.95

Daily Range

$21.63 - $22.34

52-Week Range

$14.45 - $28.35

Dividend

$0.00

Beta (Volatility)

0.96 (Low)

Price

$21.96

Volume

1,449,400.349

Open

$22.31

Previous Close

$21.95

Daily Range

$21.63 - $22.34

52-Week Range

$14.45 - $28.35

ACAD News

Acadia Stock Up 59% in a Year — Is a $51 Million New Stake a Bet on a Bigger Rebound?

Jonathan PoncianoDec 3, 2025

Page 1

ACAD: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Acadia Pharmaceuticals

Industry

Biotechnology

Sector

Health Care

Employees

798

CEO

Catherine Owen Adams

Website

www.acadia.com

Headquarters

San Diego, CA 92130, US

ACAD Financials

Key Financial Metrics (TTM)

Gross Margin

92%

Operating Margin

10%

Net Income Margin

36%

Return on Equity

40%

Return on Capital

Return on Assets

25%

Earnings Yield

10.43%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$3.76B

Shares Outstanding

171.22M

Volume

1.45M

Avg. Volume

1.82M

Financials (TTM)

Gross Profit

$982.51M

Operating Income

$104.81M

EBITDA

$138.90M

Operating Cash Flow

$109.84M

Capital Expenditure

$4.69M

Free Cash Flow

$105.15M

Cash & ST Invst.

$819.69M

Total Debt

$52.19M

Acadia Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$283.99M

+9.4%

Gross Profit

$257.76M

+8.4%

Gross Margin

90.77%

N/A

Market Cap

$3.76B

N/A

Market Cap/Employee

$5.76M

N/A

Employees

653

N/A

Net Income

$273.57M

+90.3%

EBITDA

$26.32M

+115.7%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$767.50M

+9.0%

Accounts Receivable

$148.23M

+41.6%

Inventory

$34.67M

+58.0%

Long Term Debt

$40.55M

-3.5%

Short Term Debt

$11.63M

+16.8%

Return on Assets

25.00%

N/A

Return on Invested Capital

8.14%

N/A

Free Cash Flow

$52.74M

-232.1%

Operating Cash Flow

$48.73M

-220.7%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

VKTXViking Therapeutics, Inc.

VKTXViking Therapeutics, Inc.$30.00-3.78%

CRNXCrinetics Pharmaceuticals, Inc.

CRNXCrinetics Pharmaceuticals, Inc.$39.02+0.62%

LGNDLigand Pharmaceuticals Incorporated

LGNDLigand Pharmaceuticals Incorporated$227.44-0.88%

DYNDyne Therapeutics, Inc.

DYNDyne Therapeutics, Inc.$17.39-0.91%

SLNOSoleno Therapeutics, Inc.

SLNOSoleno Therapeutics, Inc.$52.87+0.09%

MIRMMirum Pharmaceuticals, Inc.

MIRMMirum Pharmaceuticals, Inc.$96.53-0.80%

ADMAADMA Biologics, Inc.

ADMAADMA Biologics, Inc.$10.52+2.63%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.30+0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.70+0.01%

SOFISoFi Technologies

SOFISoFi Technologies$16.43+0.02%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.30+0.03%

NIONio

NIONio$5.91-0.08%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$50.22-0.03%

Questions About ACAD

What is the current price of Acadia Pharmaceuticals?

Acadia Pharmaceuticals is trading at $21.95 per share.

What is the 52-week range for Acadia Pharmaceuticals?

Over the past 52 weeks, Acadia Pharmaceuticals has traded between $14.45 and $28.35.

How much debt does Acadia Pharmaceuticals have?

As of the most recent reporting period, Acadia Pharmaceuticals reported total debt of $52.19M.

How much cash does Acadia Pharmaceuticals have on hand?

Acadia Pharmaceuticals reported $177.69M in cash and cash equivalents in its most recent financial results.

What is Acadia Pharmaceuticals’s dividend yield?

Acadia Pharmaceuticals does not currently have a dividend yield.

Acadia Pharmaceuticals

Acadia Pharmaceuticals Financials at a Glance

ACAD News

Acadia Stock Up 59% in a Year — Is a $51 Million New Stake a Bet on a Bigger Rebound?

Acadia (ACAD) Q2 Revenue Rises 9%

Why Acadia Pharmaceuticals Stock Is Rising Today

2 Growth Stocks I'd Buy on the Dip

2 Supercharged Growth Stocks Billionaires Can't Stop Buying

Can This Red-Hot Biotech Stock Keep Beating the Broader Markets?

Why These 2 Biotech Stocks Made Big Moves Late Thursday

3 Nasdaq Stocks on Watch This Week

ACAD: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Acadia Pharmaceuticals

ACAD Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Acadia Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ACAD

What is the current price of Acadia Pharmaceuticals?

What is the 52-week range for Acadia Pharmaceuticals?

How much debt does Acadia Pharmaceuticals have?

How much cash does Acadia Pharmaceuticals have on hand?

What is Acadia Pharmaceuticals’s dividend yield?

Premium Investing Services